Kurt Lucin Explains How Alzheimer’s Disease Might Progress
Published on April 10, 2019
Kurt Lucin Explains How Alzheimer’s Disease Might Progress
On April 3, Kurt Lucin, assistant professor of biology, continued the Faculty Scholars Forum with a discussion on Alzheimer’s Disease (AD), a debilitating neurological disease that affects a growing number of elderly people.
Lucin says AD is characterized by a progressive loss of cells in the brain and a concomitant decline in cognitive function.
“These impairments are associated with the appearance of amyloid plaques and neurofibrillary tangles within the brain.”
Lucin said previous studies indicate that AD is accompanied by reduced levels of the protein beclin 1 within diseased regions of the brain. Beclin 1 is involved in numerous processes, including a cellular degradation process, called autophagy, and the trafficking of recognition molecules called receptors.
“My research is interested in understanding the consequences of reduced beclin 1 on disease progression,” said Lucin. “We are particularly interested in understanding how reduced beclin 1 may affect the function of astrocytes. Astrocytes are the most numerous cell in the brain, provide neuronal support, and are capable of internalizing and degrading amyloid plaques via a process called phagocytosis.”